{"url_path":"/sec/lmri/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/2071288/0001193125-26-219480-index.html","accession_number":"0001193125-26-219480","cik":"0002071288","ticker":"LMRI","issuer_name":"Lumexa Imaging Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2071288/0001193125-26-219480-index.html","primary_entity_key":"0002071288","primary_entity_name":"Lumexa Imaging Holdings, Inc."},"word_count":97,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\nOn December 14, 2025, in connection with our formation, we sold 1,000 shares of our common stock to Holdings LLC for aggregate consideration of $1.00. No underwriters were involved in the foregoing sale of securities. The shares of our common stock described above were issued in reliance on the exemption contained in Section 4(a)(2) of the Securities Act on the basis that the transaction did not involve a public offering.\n\nWe did not repurchase any of our common stock during the quarter ended March 31, 2026."}